Exosomal Non-coding RNA Derived from Mesenchymal Stem Cells (MSCs) in Autoimmune Diseases Progression and Therapy; an Updated Review.
Long non-coding RNAs
Autoimmune diseases
Mesenchymal stem cells
MicroRNAs
Non-coding RNAs
Journal
Cell biochemistry and biophysics
ISSN: 1559-0283
Titre abrégé: Cell Biochem Biophys
Pays: United States
ID NLM: 9701934
Informations de publication
Date de publication:
03 Sep 2024
03 Sep 2024
Historique:
accepted:
11
07
2024
medline:
3
9
2024
pubmed:
3
9
2024
entrez:
3
9
2024
Statut:
aheadofprint
Résumé
Inflammation and autoimmune diseases (AD) are common outcomes of an overactive immune system. Inflammation occurs due to the immune system reacting to damaging stimuli. Exosomes are being recognized as an advanced therapeutic approach for addressing an overactive immune system, positioning them as a promising option for treating AD. Mesenchymal stem cells (MSCs) release exosomes that have strong immunomodulatory effects, influenced by their cell of origin. MSCs-exosomes, being a cell-free therapy, exhibit less toxicity and provoke a diminished immune response compared to cell-based therapies. Exosomal non-coding RNAs (ncRNA), particularly microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are intricately linked to various biological and functional aspects of human health. Exosomal ncRNAs can lead to tissue malfunction, aging, and illnesses when they experience tissue-specific alterations as a result of various internal or external problems. In this study, we will examine current trends in exosomal ncRNA researches regarding AD. Then, therapeutic uses of MSCs-exosomal ncRNA will be outlined, with a particle focus on the underlying molecular mechanisms.
Identifiants
pubmed: 39225902
doi: 10.1007/s12013-024-01432-4
pii: 10.1007/s12013-024-01432-4
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Batrakova, E. V., & Kim, M. S. (2015). Using exosomes, naturally-equipped nanocarriers, for drug delivery. Journal of Controlled Release, 219, 396–405. https://doi.org/10.1016/j.jconrel.2015.07.030 .
doi: 10.1016/j.jconrel.2015.07.030
pubmed: 26241750
pmcid: 4656109
Wang, X., Huang, J., Chen, W., Li, G., Li, Z., & Lei, J. (2022). The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancer. Experimental & Molecular Medicine, 54(9), 1390–1400. https://doi.org/10.1038/s12276-022-00855-4 .
doi: 10.1038/s12276-022-00855-4
Harrell, C. R., Simovic Markovic, B., Fellabaum, C., Arsenijevic, A., Djonov, V., Arsenijevic, N., & Volarevic, V. (2018). Therapeutic potential of mesenchymal stem cell-derived exosomes in the treatment of eye diseases. Cell Biology and Translational Medicine, Volume 2: Approaches for Diverse Diseases and Conditions. 1089, 47–57.
Harrell, C. R., Volarevic, V., Djonov, V., & Volarevic, A. (2022). Therapeutic potential of exosomes derived from adipose tissue-sourced mesenchymal stem cells in the treatment of neural and retinal diseases. International Journal of Molecular Sciences, 23(9), 4487.
pubmed: 35562878
pmcid: 9105552
doi: 10.3390/ijms23094487
Hassanzadeh, A., Rahman, H. S., Markov, A., Endjun, J. J., Zekiy, A. O., Chartrand, M. S., Beheshtkhoo, N., Kouhbanani, M. A. J., Marofi, F., Nikoo, M., & Jarahian, M. (2021). Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities. Stem Cell Research & Therapy, 12(1),297.
doi: 10.1186/s13287-021-02378-7
Tavakoli, S., Ghaderi Jafarbeigloo, H. R., Shariati, A., Jahangiryan, A., Jadidi, F., Jadidi Kouhbanani, M. A., Hassanzadeh, A., Zamani, M., Javidi, K., & Naimi, A. (2020). Mesenchymal stromal cells; a new horizon in regenerative medicine. Journal of Cellular Physiology, 235(12), 9185–9210.
pubmed: 32452052
doi: 10.1002/jcp.29803
Zhang, P., Wu, W., Chen, Q., & Che, M. (2019). Non-Coding RNAs and their Integrated Networks. Journal of Integrative Bioinformatics. 16(3). https://doi.org/10.1515/jib-2019-0027 .
Yan, H., & Bu, P. (2021). Non-coding RNA in cancer. Essays in Biochemistry, 65(4), 625–639. https://doi.org/10.1042/ebc20200032 .
doi: 10.1042/ebc20200032
pubmed: 33860799
pmcid: 8564738
Xu, Z., Chen, Y., Ma, L., Chen, Y., Liu, J., Guo, Y., Yu, T., Zhang, L., Zhu, L., & Shu, Y. (2022). Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment. Molecular Therapy, 30(10), 3133–3154. https://doi.org/10.1016/j.ymthe.2022.01.046 .
doi: 10.1016/j.ymthe.2022.01.046
pubmed: 35405312
pmcid: 9552915
Saw, P. E., Xu, X., Chen, J., & Song, E. W. (2021). Non-coding RNAs: the new central dogma of cancer biology. Science China Life Sciences, 64(1), 22–50. https://doi.org/10.1007/s11427-020-1700-9 .
doi: 10.1007/s11427-020-1700-9
pubmed: 32930921
Mercer, T. R., Dinger, M. E., & Mattick, J. S. (2009). Long non-coding RNAs: insights into functions. Nature Reviews Genetics, 10(3), 155–159. https://doi.org/10.1038/nrg2521 .
doi: 10.1038/nrg2521
pubmed: 19188922
de Almeida, R. A., Fraczek, M. G., Parker, S., Delneri, D., & O’Keefe, R. T. (2016). Non-coding RNAs and disease: the classical ncRNAs make a comeback. Biochemical Society Transactions, 44(4), 1073–1078. https://doi.org/10.1042/bst20160089 .
doi: 10.1042/bst20160089
pubmed: 27528754
pmcid: 6042638
Das, T., Das, T. K., Khodarkovskaya, A., & Dash, S. (2021). Non-coding RNAs and their bioengineering applications for neurological diseases. Bioengineered, 12(2), 11675–11698. https://doi.org/10.1080/21655979.2021.2003667 .
doi: 10.1080/21655979.2021.2003667
pubmed: 34756133
pmcid: 8810045
Chen, B., Dragomir, M. P., Yang, C., Li, Q., Horst, D., & Calin, G. A. (2022). Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct Target Therapy, 7(1), 121. https://doi.org/10.1038/s41392-022-00975-3 .
doi: 10.1038/s41392-022-00975-3
Yu, Z., Wen, Y., Jiang, N., Li, Z., Guan, J., Zhang, Y., Deng, C., Zhao, L., Zheng, S. G., Zhu, Y., Su, W., & Zhuo, Y. (2022). TNF-α stimulation enhances the neuroprotective effects of gingival MSCs derived exosomes in retinal ischemia-reperfusion injury via the MEG3/miR-21a-5p axis. Biomaterials, 284, 121484. https://doi.org/10.1016/j.biomaterials.2022.121484 .
doi: 10.1016/j.biomaterials.2022.121484
pubmed: 35378413
Yoon, D. S., Kim, E. J., Cho, S., Jung, S., Lee, K. M., Park, K. H., Lee, J. W., & Kim, S. H. (2023). RUNX2 stabilization by long non-coding RNAs contributes to hypertrophic changes in human chondrocytes. International Journal of Biological Sciences, 19(1), 13–33. https://doi.org/10.7150/ijbs.74895 .
doi: 10.7150/ijbs.74895
pubmed: 36594090
pmcid: 9760429
Walravens, A. S., Smolgovsky, S., Li, L., Kelly, L., Antes, T., Peck, K., Quon, T., Ibrahim, A., Marbán, E., Berman, B., Marbán, L., R-Borlado, L., & de Couto, G. (2021). Mechanistic and therapeutic distinctions between cardiosphere-derived cell and mesenchymal stem cell extracellular vesicle non-coding RNA. Scientific Reports, 11(1), 8666. https://doi.org/10.1038/s41598-021-87939-9 .
doi: 10.1038/s41598-021-87939-9
pubmed: 33883598
pmcid: 8060398
Nawaz, M. (2017). Extracellular vesicle-mediated transport of non-coding RNAs between stem cells and cancer cells: implications in tumor progression and therapeutic resistance. Stem Cell Investigation, 4, 83. https://doi.org/10.21037/sci.2017.10.04 .
doi: 10.21037/sci.2017.10.04
pubmed: 29167804
pmcid: 5676198
Jin, Y., Xu, M., Zhu, H., Dong, C., Ji, J., Liu, Y., Deng, A., & Gu, Z. (2021). Therapeutic effects of bone marrow mesenchymal stem cells-derived exosomes on osteoarthritis. Journal of Cellular and Molecular Medicine, 25(19), 9281–9294. https://doi.org/10.1111/jcmm.16860 .
doi: 10.1111/jcmm.16860
pubmed: 34448527
pmcid: 8500984
Fatima, F., Ekstrom, K., Nazarenko, I., Maugeri, M., Valadi, H., Hill, A. F., Camussi, G., & Nawaz, M. (2017). Non-coding RNAs in mesenchymal stem cell-derived extracellular vesicles: Deciphering regulatory roles in stem cell potency, inflammatory resolve, and tissue regeneration. Frontiers in Genetics, 8, 161. https://doi.org/10.3389/fgene.2017.00161 .
doi: 10.3389/fgene.2017.00161
pubmed: 29123544
pmcid: 5662888
Fang, J., Zhang, Y., Chen, D., Zheng, Y., & Jiang, J. (2022). Exosomes and exosomal cargos: A promising world for ventricular remodeling following myocardial infarction. International Journal of Nanomedicine, 17, 4699–4719. https://doi.org/10.2147/ijn.s377479 .
doi: 10.2147/ijn.s377479
pubmed: 36217495
pmcid: 9547598
Chen, Y., Wu, Y., Guo, L., Yuan, S., Sun, J., Zhao, K., Wang, J., & An, R. (2023). Exosomal Lnc NEAT1 from endothelial cells promote bone regeneration by regulating macrophage polarization via DDX3X/NLRP3 axis. Journal of Nanobiotechnology, 21(1), 98. https://doi.org/10.1186/s12951-023-01855-w .
doi: 10.1186/s12951-023-01855-w
pubmed: 36941678
pmcid: 10029245
Huang, P., Wang, L., Li, Q., Tian, X., Xu, J., Xu, J., Xiong, Y., Chen, G., Qian, H., Jin, C., Yu, Y., Cheng, K., Qian, L., & Yang, Y. (2020). Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovascular Research, 116(2), 353–367. https://doi.org/10.1093/cvr/cvz139 .
doi: 10.1093/cvr/cvz139
pubmed: 31119268
Hou, L., Zhu, Z., Jiang, F., Zhao, J., Jia, Q., Jiang, Q., Wang, H., Xue, W., Wang, Y., & Tian, L. (2023). Human umbilical cord mesenchymal stem cell-derived extracellular vesicles alleviated silica induced lung inflammation and fibrosis in mice via circPWWP2A/miR-223-3p/NLRP3 axis. Ecotoxicology and Environmental Safety, 251, 114537. https://doi.org/10.1016/j.ecoenv.2023.114537 .
doi: 10.1016/j.ecoenv.2023.114537
pubmed: 36646008
Zhu, L., Zhao, L., Wang, Q., Zhong, S., Guo, X., Zhu, Y., Bao, J., Xu, K., & Liu, S. (2022). Circulating exosomal miRNAs and cancer early diagnosis. Clinical & Translational Oncology, 24(3), 393–406. https://doi.org/10.1007/s12094-021-02706-6 .
doi: 10.1007/s12094-021-02706-6
Zhang, H., Ma, G., Lv, H., & Peng, Y. (2023). Bibliometric analysis of non-coding RNAs and ischemic stroke: trends, frontiers, and challenges. Molecular Biotechnology. https://doi.org/10.1007/s12033-023-00981-y .
Wang, J., Yan, S., Yang, J., Lu, H., Xu, D., & Wang, Z. (2019). Non-coding RNAs in rheumatoid arthritis: from bench to bedside. Frontiers in Immunology, 10, 3129. https://doi.org/10.3389/fimmu.2019.03129 .
doi: 10.3389/fimmu.2019.03129
pubmed: 32047497
Villarroya-Beltri, C., Gutiérrez-Vázquez, C., Sánchez-Cabo, F., Pérez-Hernández, D., Vázquez, J., Martin-Cofreces, N., Martinez-Herrera, D. J., Pascual-Montano, A., Mittelbrunn, M., & Sánchez-Madrid, F. (2013). Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nature Communications, 4, 2980. https://doi.org/10.1038/ncomms3980 .
doi: 10.1038/ncomms3980
pubmed: 24356509
Rezaie, J., Nejati, V., Mahmoodi, M., & Ahmadi, M. (2022). Mesenchymal stem cells derived extracellular vesicles: A promising nanomedicine for drug delivery system. Biochemical Pharmacology, 203, 115167. https://doi.org/10.1016/j.bcp.2022.115167 .
doi: 10.1016/j.bcp.2022.115167
pubmed: 35820499
Videira, R. F., & da Costa Martins, P. A. (2020). Non-coding RNAs in cardiac intercellular communication. Frontiers in Physiology, 11, 738. https://doi.org/10.3389/fphys.2020.00738 .
doi: 10.3389/fphys.2020.00738
pubmed: 33013428
pmcid: 7509180
Trzybulska, D., Vergadi, E., & Tsatsanis, C. (2018). miRNA and other Non-Coding RNAs as promising diagnostic markers. Ejifcc, 29(3), 221–226.
pubmed: 30479608
pmcid: 6247131
Prattichizzo, F., Micolucci, L., Cricca, M., De Carolis, S., Mensà, E., Ceriello, A., Procopio, A. D., Bonafè, M., & Olivieri, F. (2017). Exosome-based immunomodulation during aging: A nano-perspective on inflamm-aging. Mechanisms of Ageing and Development, 168, 44–53. https://doi.org/10.1016/j.mad.2017.02.008 .
doi: 10.1016/j.mad.2017.02.008
pubmed: 28259747
Hassanzadeh, A., Shamlou, S., Yousefi, N., Nikoo, M., & Verdi, J. (2022). Genetically-modified stem cell in regenerative medicine and cancer therapy; a new era. Current Gene Therapy, 22(1), 23–39.
pubmed: 34238158
Hajibabaie, F., Kouhpayeh, S., Mirian, M., Rahimmanesh, I., Boshtam, M., Sadeghian, L., Gheibi, A., Khanahmad, H., & Shariati, L. (2020). MicroRNAs as the actors in the atherosclerosis scenario. Journal of Physiology and Biochemistry, 76(1), 1–12. https://doi.org/10.1007/s13105-019-00710-7 .
doi: 10.1007/s13105-019-00710-7
pubmed: 31808077
Huang, X., Yuan, T., Tschannen, M., Sun, Z., Jacob, H., Du, M., Liang, M., Dittmar, R. L., Liu, Y., & Liang, M. J. B. G. (2013). Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics.14, 1–14.
McDonald, M. K., Tian, Y., Qureshi, R. A., Gormley, M., Ertel, A., Gao, R., Lopez, E. A., Alexander, G. M., Sacan, A., & Fortina, P. J. P. (2014). Functional significance of macrophage-derived exosomes in inflammation and pain. 155 (8), 1527–1539.
Takenaka, M. C., & Quintana, F. J. (2017). Tolerogenic dendritic cells. Seminars in immunopathology. 39, 113–120.
Hasegawa, H., & Matsumoto, T. (2018). Mechanisms of tolerance induction by dendritic cells in vivo. Frontiers in Immunology, 9, 350.
pubmed: 29535726
pmcid: 5834484
doi: 10.3389/fimmu.2018.00350
Bartel, S., La Grutta, S., Cilluffo, G., Perconti, G., Bongiovanni, A., Giallongo, A., Behrends, J., Kruppa, J., Hermann, S.,& Chiang, D. J. A. (2020). Human airway epithelial extracellular vesicle miRNA signature is altered upon asthma development. Allergy, 75 (2), 346–356.
Prado, N., Marazuela, E. G., Segura, E., Fernandez-Garcia, H., Villalba, M., Théry, C., Rodríguez, R., & Batanero, E. (2008). Exosomes from bronchoalveolar fluid of tolerized mice prevent allergic reaction. Journal of Immunology, 181(2), 1519–1525.
doi: 10.4049/jimmunol.181.2.1519
Mycko, M. P., & Baranzini, S. E. (2020). microRNA and exosome profiling in multiple sclerosis. Multiple Sclerosis Journal, 26(5), 599–604. https://doi.org/10.1177/1352458519879303 .
doi: 10.1177/1352458519879303
pubmed: 31965891
Lorente-Cebrián, S., González-Muniesa, P., Milagro, F. I., & Martínez, J. A. (2019). MicroRNAs and other non-coding RNAs in adipose tissue and obesity: emerging roles as biomarkers and therapeutic targets. Clinical Science, 133(1), 23–40. https://doi.org/10.1042/cs20180890 .
doi: 10.1042/cs20180890
pubmed: 30606812
Lai, X., Zhong, J., Zhang, B., Zhu, T., & Liao, R. (2023). Exosomal non-coding RNAs: Novel regulators of macrophage-linked intercellular communication in lung cancer and inflammatory lung diseases. Biomolecules. 13(3). https://doi.org/10.3390/biom13030536 .
Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., Van Dongen, S., Grocock, R. J., Das, P. P., & Miska, E. A. (2007). Requirement of bic/microRNA-155 for normal immune function. Science, 316(5824), 608–611.
pubmed: 17463290
pmcid: 2610435
doi: 10.1126/science.1139253
Ceppi, M., Pereira, P. M., Dunand-Sauthier, I., Barras, E., Reith, W., Santos, M. A., & Pierre, P. (2009). MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proceedings of the National Academy of Sciences, 106(8), 2735–2740.
doi: 10.1073/pnas.0811073106
O’Connell, R. M., Rao, D. S., Chaudhuri, A. A., Boldin, M. P., Taganov, K. D., Nicoll, J., Paquette, R. L., & Baltimore, D. (2008). Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. The Journal of Experimental Medicine, 205(3), 585–594.
pubmed: 18299402
pmcid: 2275382
doi: 10.1084/jem.20072108
O’Connell, R. M., Chaudhuri, A. A., Rao, D. S., & Baltimore, D. (2009). Inositol phosphatase SHIP1 is a primary target of miR-155. Proceedings of the National Academy of Sciences, 106(17), 7113–7118.
doi: 10.1073/pnas.0902636106
Paladini, L., Fabris, L., Bottai, G., Raschioni, C., Calin, G. A., & Santarpia, L. (2016). Targeting microRNAs as key modulators of tumor immune response. Journal of Experimental & Clinical Cancer Research, 35, 103. https://doi.org/10.1186/s13046-016-0375-2 .
doi: 10.1186/s13046-016-0375-2
Mehta, A., & Baltimore, D. (2016). MicroRNAs as regulatory elements in immune system logic. Nature Reviews Immunology, 16(5), 279–294. https://doi.org/10.1038/nri.2016.40 .
doi: 10.1038/nri.2016.40
pubmed: 27121651
Liu, G., & Abraham, E. (2013). MicroRNAs in immune response and macrophage polarization. Arterioscler Thrombosis and Vascular Biology, 33(2), 170–177. https://doi.org/10.1161/atvbaha.112.300068 .
doi: 10.1161/atvbaha.112.300068
Curtale, G., & Citarella, F. (2013). Dynamic nature of noncoding RNA regulation of adaptive immune response. International Journal of Molecular Science, 14(9), 17347–17377. https://doi.org/10.3390/ijms140917347 .
doi: 10.3390/ijms140917347
Cao, W., Cheng, W., & Wu, W. (2018). MicroRNAs reprogram tumor immune response. Methods in Molecular Biology, 1699, 67–74. https://doi.org/10.1007/978-1-4939-7435-1_4 .
doi: 10.1007/978-1-4939-7435-1_4
pubmed: 29086368
Du, C., Liu, C., Kang, J., Zhao, G., Ye, Z., Huang, S., Li, Z., Wu, Z., & Pei, G. (2009). MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nature Immunology, 10(12), 1252–1259.
pubmed: 19838199
doi: 10.1038/ni.1798
Chong, M. M., Rasmussen, J. P., Rudensky, A. Y., & Littman, D. R. (2008). The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. The Journal of Experimental Medicine, 205(9), 2005–2017.
pubmed: 18725527
pmcid: 2526196
doi: 10.1084/jem.20081219
Yu, D., Rao, S., Tsai, L. M., Lee, S. K., He, Y., Sutcliffe, E. L., Srivastava, M., Linterman, M., Zheng, L., & Simpson, N. (2009). The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity, 31(3), 457–468.
pubmed: 19631565
doi: 10.1016/j.immuni.2009.07.002
Zhou, B., Wang, S., Mayr, C., Bartel, D. P., & Lodish, H. F. (2007). miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proceedings of the National Academy of Sciences, 104(17), 7080–7085.
doi: 10.1073/pnas.0702409104
Xiao, C., Calado, D. P., Galler, G., Thai, T.-H., Patterson, H. C., Wang, J., Rajewsky, N., Bender, T. P., & Rajewsky, K. (2007). MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell, 131(1), 146–159.
pubmed: 17923094
doi: 10.1016/j.cell.2007.07.021
Wufuer, A., Luohemanjiang, X., Du, L., Lei, J., Shabier, M., Han, D. F., & Ma, J. (2023). ANRIL overexpression globally induces expression and alternative splicing of genes involved in inflammation in HUVECs. Molecular Medicine Reports. 27(2). https://doi.org/10.3892/mmr.2022.12915 .
Rahni, Z., Hosseini, S. M., Shahrokh, S., Saeedi Niasar, M., Shoraka, S., Mirjalali, H., Nazemalhosseini-Mojarad, E., Rostami-Nejad, M., Malekpour, H., Zali, M. R., & Mohebbi, S. R. (2023). Long non-coding RNAs ANRIL, THRIL, and NEAT1 as potential circulating biomarkers of SARS-CoV-2 infection and disease severity. Virus Research, 336, 199214. https://doi.org/10.1016/j.virusres.2023.199214 .
doi: 10.1016/j.virusres.2023.199214
pubmed: 37657511
pmcid: 10502354
Zhou, X., Han, X., Wittfeldt, A., Sun, J., Liu, C., Wang, X., Gan, L. M., Cao, H., & Liang, Z. (2016). Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway. RNA Biology, 13(1), 98–108. https://doi.org/10.1080/15476286.2015.1122164 .
doi: 10.1080/15476286.2015.1122164
pubmed: 26618242
Chan, J., Atianand, M., Jiang, Z., Carpenter, S., Aiello, D., Elling, R., Fitzgerald, K. A., & Caffrey, D. R. (2015). Cutting edge: A natural antisense transcript, AS-IL1α, controls inducible transcription of the proinflammatory Cytokine IL-1α. Journal of Immunology, 195(4), 1359–1363. https://doi.org/10.4049/jimmunol.1500264 .
doi: 10.4049/jimmunol.1500264
Almohammai, A., Rahbarghazi, R., Keyhanmanesh, R., Rezaie, J., & Ahmadi, M. (2021). Asthmatic condition induced the activity of exosome secretory pathway in rat pulmonary tissues. Journal of Inflammation, 18(1), 14. https://doi.org/10.1186/s12950-021-00275-7 .
doi: 10.1186/s12950-021-00275-7
pubmed: 33794910
pmcid: 8015058
Hedayat, M., Ahmadi, M., Shoaran, M., & Rezaie, J. (2023). Therapeutic application of mesenchymal stem cells derived exosomes in neurodegenerative diseases: A focus on non-coding RNAs cargo, drug delivery potential, perspective. Life Sciences, 320, 121566. https://doi.org/10.1016/j.lfs.2023.121566 .
doi: 10.1016/j.lfs.2023.121566
pubmed: 36907326
Zhan, D. T., & Xian, H. C. (2023). Exploring the regulatory role of lncRNA in cancer immunity. Frontiers in Oncology, 13, 1191913. https://doi.org/10.3389/fonc.2023.1191913 .
doi: 10.3389/fonc.2023.1191913
pubmed: 37637063
pmcid: 10448763
Zeni, P. F., & Mraz, M. (2021). LncRNAs in adaptive immunity: role in physiological and pathological conditions. RNA Biology, 18(5), 619–632. https://doi.org/10.1080/15476286.2020.1838783 .
doi: 10.1080/15476286.2020.1838783
pubmed: 33094664
Papaioannou, E., González-Molina, M. D. P., Prieto-Muñoz, A. M., Gámez-Reche, L., & González-Martín, A. (2021). Regulation of Adaptive Tumor Immunity by Non-Coding RNAs. Cancers. 13 (22). https://doi.org/10.3390/cancers13225651 .
Li, X., & Li, N. (2018). LncRNAs on guard. International Immunopharmacology, 65, 60–63. https://doi.org/10.1016/j.intimp.2018.09.031 .
doi: 10.1016/j.intimp.2018.09.031
pubmed: 30286432
Kuo, G., Wu, C. Y., & Yang, H. Y. (2019). MiR-17-92 cluster and immunity. Journal of the Formosan Medical Association, 118(1 Pt 1), 2–6. https://doi.org/10.1016/j.jfma.2018.04.013 .
doi: 10.1016/j.jfma.2018.04.013
pubmed: 29857952
Fok, E. T., Davignon, L., Fanucchi, S., & Mhlanga, M. M. (2018). The lncRNA connection between cellular metabolism and epigenetics in trained immunity. Frontiers in Immunology, 9, 3184. https://doi.org/10.3389/fimmu.2018.03184 .
doi: 10.3389/fimmu.2018.03184
pubmed: 30761161
Ahani‐Nahayati, M., Shariati, A., Mahmoodi, M., Olegovna Zekiy, A., Javidi, K., Shamlou, S., Mousakhani, A., Zamani, M., & Hassanzadeh, A. (2021). Stem cell in neurodegenerative disorders; an emerging strategy. International Society for Developmental Neuroscience, 81(4), 291–311.
doi: 10.1002/jdn.10101
Hassanzadeh, A., Vousooghi, N., Rahimnia, R., Razeghian, E., Rajaeian, S., Seyhoun, I., Sharif, S., & Verdi, J. (2023). Recent advances in mesenchymal stem/stromal cells (MSCs)‐based approaches for osteoarthritis (OA) therapy. Cell Biology International, 47(6), 1033–1048.
pubmed: 36994843
doi: 10.1002/cbin.12008
Marofi, F., Shomali, N., Younus, L. A., Hassanzadeh, A., Vahedi, G., Kuznetsova, M. Y., Solali, S., Gharibi, T., Hosseini, A., & Mohammed, A. (2022). Under hypoxic conditions, MSCs affect the expression and methylation level of survival‐related genes in ALL independent of apoptosis pathways in vitro. Biotechnology and Applied Biochemistry, 69 (2): 822–839.
Zhang, M., Johnson-Stephenson, T. K., Wang, W., Wang, Y., Li, J., Li, L., Zen, K., Chen, X., & Zhu, D. (2022). Mesenchymal stem cell-derived exosome-educated macrophages alleviate systemic lupus erythematosus by promoting efferocytosis and recruitment of IL-17(+) regulatory T cell. Stem Cell Research & Therapy, 13(1), 484. https://doi.org/10.1186/s13287-022-03174-7 .
doi: 10.1186/s13287-022-03174-7
Zhang, J., Buller, B. A., Zhang, Z. G., Zhang, Y., Lu, M., Rosene, D. L., Medalla, M., Moore, T. L., & Chopp, M. (2022). Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system. Experimental Neurology, 347, 113895. https://doi.org/10.1016/j.expneurol.2021.113895 .
doi: 10.1016/j.expneurol.2021.113895
pubmed: 34653510
Xiong, J., Hu, H., Guo, R., Wang, H., & Jiang, H. (2021). Mesenchymal stem cell exosomes as a new strategy for the treatment of diabetes complications. Frontiers in Endocrinology, 12, 646233. https://doi.org/10.3389/fendo.2021.646233 .
doi: 10.3389/fendo.2021.646233
pubmed: 33995278
pmcid: 8117220
Wang, L. T., Liu, K. J., Sytwu, H. K., Yen, M. L., & Yen, B. L. (2021). Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells. Stem Cells Translational Medicine, 10(9), 1288–1303. https://doi.org/10.1002/sctm.21-0021 .
doi: 10.1002/sctm.21-0021
pubmed: 34008922
pmcid: 8380447
Shen, Z., Huang, W., Liu, J., Tian, J., Wang, S., & Rui, K. (2021). Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases. Frontiers in Immunology, 12, 749192. https://doi.org/10.3389/fimmu.2021.749192 .
doi: 10.3389/fimmu.2021.749192
pubmed: 34646275
pmcid: 8503317
Liu, H., Li, R., Liu, T., Yang, L., Yin, G., & Xie, Q. (2020). Immunomodulatory effects of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles in rheumatoid arthritis. Frontiers in Immunology, 11, 1912. https://doi.org/10.3389/fimmu.2020.01912 .
doi: 10.3389/fimmu.2020.01912
pubmed: 32973792
pmcid: 7468450
Rezaie, J., Etemadi, T., & Feghhi, M. (2022). The distinct roles of exosomes in innate immune responses and therapeutic applications in cancer. European Journal of Pharmacology, 933, 175292. https://doi.org/10.1016/j.ejphar.2022.175292 .
doi: 10.1016/j.ejphar.2022.175292
pubmed: 36150532
Kim, D., Lee, A. E., Xu, Q., Zhang, Q., & Le, A. D. (2021). Gingiva-derived mesenchymal stem cells: Potential application in tissue engineering and regenerative medicine - a comprehensive review. Frontiers in Immunology, 12, 667221. https://doi.org/10.3389/fimmu.2021.667221 .
doi: 10.3389/fimmu.2021.667221
pubmed: 33936109
pmcid: 8085523
Chen, T., Ji, J., & Gu, Z. F. (2022). The therapeutic role of mesenchymal stem cell-derived exosomes in the autoimmune diseases. Sheng li xue bao [Acta Physiologica Sinica], 74(4), 609–620.
pubmed: 35993212
Arabpour, M., Saghazadeh, A., & Rezaei, N. (2021). Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes. International Immunopharmacology, 97, 107823. https://doi.org/10.1016/j.intimp.2021.107823 .
doi: 10.1016/j.intimp.2021.107823
pubmed: 34102486
Su, Y., Liu, Y., Ma, C., Guan, C., Ma, X., & Meng, S. (2021). Mesenchymal stem cell-originated exosomal lncRNA HAND2-AS1 impairs rheumatoid arthritis fibroblast-like synoviocyte activation through miR-143-3p/TNFAIP3/NF-κB pathway. Journal of Orthopedic Surgery and Research, 16(1), 1–14.
Mi, L., Gao, J., Li, N., Liu, Y., Zhang, N., Gao, Y., Peng, X., Zhang, L., & Xu, K. (2024). Human umbilical cord mesenchymal stem cell-derived exosomes loaded miR-451a targets ATF2 to improve rheumatoid arthritis. International Immunopharmacology, 127, 111365.
pubmed: 38104370
doi: 10.1016/j.intimp.2023.111365
Taj, S. H., Kho, W., Riou, A., Wiedermann, D., & Hoehn, M. J. B. (2016). MiRNA-124 induces neuroprotection and functional improvement after focal cerebral ischemia. Biomaterials, 91, 151–165.
Nakamachi, Y., Ohnuma, K., Uto, K., Noguchi, Y., Saegusa, J., & Kawano, S. (2016). MicroRNA-124 inhibits the progression of adjuvant-induced arthritis in rats. Annals of the Rheumatic Diseases, 75(3), 601–608.
pubmed: 25596157
doi: 10.1136/annrheumdis-2014-206417
Nakamachi, Y., Kawano, S., Takenokuchi, M., Nishimura, K., Sakai, Y., Chin, T., Saura, R., Kurosaka, M., & Kumagai, S. J. A. (2009). Rheumatism, MicroRNA‐124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast‐like synoviocytes from patients with rheumatoid arthritis. Arthritis & Rhemuatism, 60(5), 1294–1304.
Wang, Y., Dai, L., Wu, H., Zhang, Z.-R., Wang, W.-Y., Fu, J., Deng, R., Li, F., Dai, X.-J., & Zhan, X. J. I. I. (2018). Novel anti-inflammatory target of geniposide: inhibiting Itgβ1/Ras-Erk1/2 signal pathway via the miRNA-124a in rheumatoid arthritis synovial fibroblasts. International Immunopharmacology, 65, 284–294
Meng, H.-Y., Chen, L.-Q., & Chen, L.-H. (2020). The inhibition by human MSCs-derived miRNA-124a overexpression exosomes in the proliferation and migration of rheumatoid arthritis-related fibroblast-like synoviocyte cell. BMC Musculoskeletal Disorders, 21, 1–10.
doi: 10.1186/s12891-020-3159-y
Huang, Y., Chen, L., Chen, D., Fan, P., & Yu, H. (2022). Exosomal microRNA-140-3p from human umbilical cord mesenchymal stem cells attenuates joint injury of rats with rheumatoid arthritis by silencing SGK1. Molecular Medicine, 28(1), 1–14.
doi: 10.1186/s10020-022-00451-2
Hu, J., Liu, X., Chi, J., Che, K., Ma, X., Qiu, M., Fu, Z., Wang, Y., Wang, Y., & Wang, W. (2022). Resveratrol enhances wound healing in type 1 diabetes mellitus by promoting the expression of extracellular vesicle-carried microRNA-129 derived from mesenchymal stem cells. Journal of Proteome Research, 21(2), 313–324.
pubmed: 35076227
doi: 10.1021/acs.jproteome.1c00248
Han, Z.-F., Cao, J.-H., Liu, Z.-Y., Yang, Z., Qi, R.-X., & Xu, H.-L. (2022). Exosomal lncRNA KLF3-AS1 derived from bone marrow mesenchymal stem cells stimulates angiogenesis to promote diabetic cutaneous wound healing. Diabetes Research and Clinical Practice, 183, 109126.
pubmed: 34742784
doi: 10.1016/j.diabres.2021.109126
Cao, X., Xue, L.-D., Di, Y., Li, T., Tian, Y.-J., & Song, Y. (2021). MSC-derived exosomal lncRNA SNHG7 suppresses endothelial-mesenchymal transition and tube formation in diabetic retinopathy via miR-34a-5p/XBP1 axis. Life sciences, 272, 119232.
pubmed: 33600866
doi: 10.1016/j.lfs.2021.119232
Li, Z., Wang, R., Wang, D., Zhang, S., Song, H., Ding, S., Zhu, Y., Wen, X., Li, H., & Chen, H. (2023). Circulating miR-320b Contributes to CD4+ T-Cell proliferation in systemic lupus erythematosus via MAP3K1. Journal of Immunology Research, 2023, 6696967.
Tu, J., Zheng, N., Mao, C., Liu, S., Zhang, H., & Sun, L. (2022). UC-BSCs exosomes regulate Th17/Treg balance in patients with systemic lupus erythematosus via miR-19b/KLF13. Cells, 11(24), 4123.
pubmed: 36552891
pmcid: 9777319
doi: 10.3390/cells11244123
Dong, C., Zhou, Q., Fu, T., Zhao, R., Yang, J., Kong, X., Zhang, Z., Sun, C., Bao, Y., & Ge, X. (2019). Circulating exosomes derived-miR-146a from systemic lupus erythematosus patients regulates senescence of mesenchymal stem cells. BioMed Research International. 2019, 6071308.
Fan, J., Han, Y., Sun, H., Sun, S., Wang, Y., Guo, R., Guo, J., Tian, X., Wang, J., & Wang, J. (2023). Mesenchymal stem cell-derived exosomal microRNA-367–3p alleviates experimental autoimmune encephalomyelitis via inhibition of microglial ferroptosis by targeting EZH2. Biomedicine & Pharmacotherapy, 162, 114593.
doi: 10.1016/j.biopha.2023.114593
Yu, Z., Wen, Y., Jiang, N., Li, Z., Guan, J., Zhang, Y., Deng, C., Zhao, L., Zheng, S. G., & Zhu, Y. (2022). TNF-α stimulation enhances the neuroprotective effects of gingival MSCs derived exosomes in retinal ischemia-reperfusion injury via the MEG3/miR-21a-5p axis. Biomaterials, 284, 121484.
pubmed: 35378413
doi: 10.1016/j.biomaterials.2022.121484
Wang, X., Li, W., Hao, M., Yang, Y., & Xu, Y. (2023). Hypoxia-treated umbilical mesenchymal stem cell alleviates spinal cord ischemia-reperfusion injury in SCI by circular RNA circOXNAD1/miR-29a-3p/FOXO3a axis. Biochemistry and Biophysics Reports, 34, 101458.
pubmed: 36969321
pmcid: 10033311
doi: 10.1016/j.bbrep.2023.101458
Wang, D., Xue, H., Tan, J., Liu, P., Qiao, C., Pang, C., & Zhang, L. (2022). Bone marrow mesenchymal stem cells-derived exosomes containing miR-539-5p inhibit pyroptosis through NLRP3/caspase-1 signalling to alleviate inflammatory bowel disease. Inflammation Research, 71(7-8), 833–846.
pubmed: 35637388
doi: 10.1007/s00011-022-01577-z
Gu, L., Ren, F., Fang, X., Yuan, L., Liu, G., & Wang, S. (2021). Exosomal MicroRNA-181a derived from mesenchymal stem cells improves gut microbiota composition, barrier function, and inflammatory status in an experimental colitis model. Frontiers in Medicine, 8, 660614.
pubmed: 34249964
pmcid: 8264068
doi: 10.3389/fmed.2021.660614
Kang, J., Zhang, Z., Wang, J., Wang, G., Yan, Y., Qian, H., Zhang, X., Xu, W., & Mao, F. (2019). hucMSCs attenuate IBD through releasing miR148b-5p to inhibit the expression of 15-lox-1 in macrophages. Mediators of Inflammation, 2019, 6953963.
Sondag, G. R., & Haqqi, T. M. (2016). The role of MicroRNAs and their targets in Osteoarthritis. Current Rheumatology Reports, 18(8), 56. https://doi.org/10.1007/s11926-016-0604-x .
doi: 10.1007/s11926-016-0604-x
pubmed: 27402113
pmcid: 5294969
Lin, H. Y., Yang, Y. L., Wang, P. W., Wang, F. S., & Huang, Y. H. (2020). The emerging role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in modulating oxidative stress, inflammation, and beyond. Cells, 9(4). https://doi.org/10.3390/cells9041041 .
Ginckels, P., & Holvoet, P. (2022). Oxidative stress and inflammation in cardiovascular diseases and cancer: Role of non-coding RNAs. The Yale Journal of Biology and Medicine, 95(1), 129–152.
pubmed: 35370493
pmcid: 8961704
Das, K., & Rao, L. V. M. (2022). The Role of microRNAs in Inflammation. International Journal of Molecular Science, 23(24). https://doi.org/10.3390/ijms232415479 .
Yuan, M., Wang, S., Yu, L., Qu, B., Xu, L., Liu, L., Sun, H., Li, C., Shi, Y., & Liu, H. (2017). Long noncoding RNA profiling revealed differentially expressed lncRNAs associated with disease activity in PBMCs from patients with rheumatoid arthritis. PloS ONE, 12(11), e0186795.
pubmed: 29140972
pmcid: 5687725
doi: 10.1371/journal.pone.0186795
Di, W., Li, Q., Shen, W., Guo, H., & Zhao, S. (2017). The long non-coding RNA HOTAIR promotes thyroid cancer cell growth, invasion and migration through the miR-1-CCND2 axis. American Journal of Cancer Research, 7(6), 1298.
pubmed: 28670492
pmcid: 5489779
Song, J., Kim, D., Han, J., Kim, Y., Lee, M., & Jin, E.-J. (2015). PBMC and exosome-derived Hotair is a critical regulator and potent marker for rheumatoid arthritis. Clinical and Experimental Medicine, 15, 121–126.
pubmed: 24722995
doi: 10.1007/s10238-013-0271-4
Mo, B. Y., Guo, X. H., Yang, M. R., Liu, F., Bi, X., Liu, Y., Fang, L. K., Luo, X. Q., Wang, J., & Bellanti, J. A. (2018). Long non-coding RNA GAPLINC promotes tumor-like biologic behaviors of fibroblast-like synoviocytes as microRNA sponging in rheumatoid arthritis patients. Frontiers in Immunology, 9, 702.
pubmed: 29692777
pmcid: 5902673
doi: 10.3389/fimmu.2018.00702
Ye, Y., Gao, X., & Yang, N. (2018). LncRNA ZFAS1 promotes cell migration and invasion of fibroblast-like synoviocytes by suppression of miR-27a in rheumatoid arthritis. Human Cell, 31, 14–21.
pubmed: 28721682
doi: 10.1007/s13577-017-0179-5
Mayama, T., Marr, A., & Kino, T. (2016). Differential expression of glucocorticoid receptor noncoding RNA repressor Gas5 in autoimmune and inflammatory diseases. Hormone and Metabolic Research, 48(08), 550–557.
pubmed: 27214311
doi: 10.1055/s-0042-106898
Zhang, F., Wu, L., Qian, J., Qu, B., Xia, S., La, T., Wu, Y., Ma, J., Zeng, J., & Guo, Q. (2016). Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus. Journal of Autoimmunity, 75, 96–104.
pubmed: 27481557
doi: 10.1016/j.jaut.2016.07.012
Xue, Z., Cui, C., Liao, Z., Xia, S., Zhang, P., Qin, J., Guo, Q., Chen, S., Fu, Q., & Yin, Z. (2018). Identification of LncRNA Linc00513 containing lupus-associated genetic variants as a novel regulator of interferon signaling pathway. Frontiers in Immunology, 9, 2967.
pubmed: 30619325
pmcid: 6305415
doi: 10.3389/fimmu.2018.02967
Wu, G.-C., Li, J., Leng, R.-X., Li, X.-P., Li, X.-M., Wang, D.-G., Pan, H.-F., & Ye, D.-Q. (2017). Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus. Oncotarget, 8(14), 23650.
pubmed: 28423570
pmcid: 5410334
doi: 10.18632/oncotarget.15569
Cao, H. Y., Li, D., Wang, Y. P., Lu, H. X., Sun, J., & Li, H. B. (2020). Clinical significance of reduced expression of lncRNA TUG1 in the peripheral blood of systemic lupus erythematosus patients. International Journal of Rheumatic Diseases, 23(3), 428–434.
pubmed: 31944629
doi: 10.1111/1756-185X.13786
Santoro, M., Nociti, V., Lucchini, M., De Fino, C., Losavio, F. A., & Mirabella, M. (2016). Expression profile of long non-coding RNAs in serum of patients with multiple sclerosis. Journal of Molecular Neuroscience, 59, 18–23.
pubmed: 27034068
doi: 10.1007/s12031-016-0741-8
Eftekharian, M. M., Ghafouri-Fard, S., Soudyab, M., Omrani, M. D., Rahimi, M., Sayad, A., Komaki, A., Mazdeh, M., & Taheri, M. (2017). Expression analysis of long non-coding RNAs in the blood of multiple sclerosis patients. Journal of Molecular Neuroscience, 63, 333–341.
pubmed: 28967047
doi: 10.1007/s12031-017-0982-1
Sun, D., Yu, Z., Fang, X., Liu, M., Pu, Y., Shao, Q., Wang, D., Zhao, X., Huang, A., & Xiang, Z. (2017). Lnc RNA GAS 5 inhibits microglial M2 polarization and exacerbates demyelination. EMBO Reports, 18(10), 1801–1816.
pubmed: 28808113
pmcid: 5623836
doi: 10.15252/embr.201643668
Fenoglio, C., Oldoni, E., Serpente, M., Milena, A., Arcaro, M., D’Anca, M., Pietroboni, A. M., Calvi, A., Lecchi, E., & Goris, A. (2018). LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients. Journal of Neuroimmunology, 324, 129–135.
pubmed: 30170791
doi: 10.1016/j.jneuroim.2018.08.008
Hosseini, A., Teimuri, S., Ehsani, M., Rasa, S. M. M., Etemadifar, M., Nasr Esfahani, M. H., Megraw, T. L., & Ghaedi, K. (2019). LncRNAs associated with multiple sclerosis expressed in the Th1 cell lineage. Journal of Cellular Physiology, 234(12), 22153–22162.
pubmed: 31066039
doi: 10.1002/jcp.28779
Morán, I., Akerman, I., Van De Bunt, M., Xie, R., Benazra, M., Nammo, T., Arnes, L., Nakić, N., García-Hurtado, J., & Rodríguez-Seguí, S. (2012). Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metabolism, 16(4), 435–448.
pubmed: 23040067
pmcid: 3475176
doi: 10.1016/j.cmet.2012.08.010
Akerman, I., Tu, Z., Beucher, A., Rolando, D. M., Sauty-Colace, C., Benazra, M., Nakic, N., Yang, J., Wang, H., & Pasquali, L. (2017). Human pancreatic β cell lncRNAs control cell-specific regulatory networks. Cell Metabolism, 25(2), 400–411.
pubmed: 28041957
pmcid: 5300904
doi: 10.1016/j.cmet.2016.11.016
Ding, H., Wang, F., Shi, X., Ma, H., Du, Y., Hou, L., & Xing, N. (2020). LncRNA MALAT1 induces the dysfunction of β cells via reducing the histone acetylation of the PDX-1 promoter in type 1 diabetes. Experimental and Molecular Pathology, 114, 104432.
pubmed: 32243891
doi: 10.1016/j.yexmp.2020.104432
Yin, D.-D., Zhang, E.-B., You, L.-H., Wang, N., Wang, L.-T., Jin, F.-Y., Zhu, Y.-N., Cao, L.-H., Yuan, Q.-X., & De, W. (2015). Downregulation of lncRNA TUG1 affects apoptosis and insulin secretion in mouse pancreatic β cells. Cellular Physiology and Biochemistry, 35(5), 1892–1904.
pubmed: 25871529
doi: 10.1159/000373999
Le Thomas, A., Tóth, K. F., & Aravin, A. A. (2014). To be or not to be a piRNA: genomic origin and processing of piRNAs. Genome Biology, 15(1), 1–6.
doi: 10.1186/gb4154
Dallaire, A., Frédérick, P.-M., & Simard, M. J. (2018). Somatic and germline microRNAs form distinct silencing complexes to regulate their target mRNAs differently. Developmental Cell, 47(2), 239–247.
pubmed: 30245155
doi: 10.1016/j.devcel.2018.08.022
Tóth, K. F., Pezic, D., Stuwe, E., & Webster, A. (2016). The piRNA pathway guards the germline genome against transposable elements. Non-coding RNA and the Reproductive System, 3, 51–77.
doi: 10.1007/978-94-017-7417-8_4
Ha, M., & Kim, V. N. (2014). Regulation of microRNA biogenesis. Nature Reviews Molecular Cell biology, 15(8), 509–524.
pubmed: 25027649
doi: 10.1038/nrm3838
De Rie, D., Abugessaisa, I., Alam, T., Arner, E., Arner, P., Ashoor, H., Åström, G., Babina, M., Bertin, N., & Burroughs, A. M. (2017). An integrated expression atlas of miRNAs and their promoters in human and mouse. Nature Biotechnology, 35(9), 872–878.
pubmed: 28829439
pmcid: 5767576
doi: 10.1038/nbt.3947
Kim, Y. K., & Kim, V. N. (2007). Processing of intronic microRNAs. The EMBO Journal, 26(3), 775–783.
pubmed: 17255951
pmcid: 1794378
doi: 10.1038/sj.emboj.7601512
Tanzer, A., & Stadler, P. F. (2004). Molecular evolution of a microRNA cluster. Journal of Molecular Biology, 339(2), 327–335.
pubmed: 15136036
doi: 10.1016/j.jmb.2004.03.065
Denli, A. M., Tops, B. B., Plasterk, R. H., Ketting, R. F., & Hannon, G. J. (2004). Processing of primary microRNAs by the Microprocessor complex. Nature, 432(7014), 231–235.
pubmed: 15531879
doi: 10.1038/nature03049
Alarcón, C. R., Lee, H., Goodarzi, H., Halberg, N., & Tavazoie, S. F. (2015). N 6-methyladenosine marks primary microRNAs for processing. Nature, 519(7544), 482–485.
pubmed: 25799998
pmcid: 4475635
doi: 10.1038/nature14281
Martinez-Arroyo, O., Ortega, A., Forner, M. J., & Cortes, R. (2022). Mesenchymal stem cell-derived extracellular vesicles as non-coding RNA therapeutic vehicles in autoimmune diseases. Pharmaceutics, 4(4). https://doi.org/10.3390/pharmaceutics14040733 .
El-Jawhari, J. J., El-Sherbiny, Y., McGonagle, D., & Jones, E. (2021). Multipotent mesenchymal stromal cells in rheumatoid arthritis and systemic lupus erythematosus; from a leading role in pathogenesis to potential therapeutic saviors? Frontiers in Immunology, 12, 643170.
pubmed: 33732263
pmcid: 7959804
doi: 10.3389/fimmu.2021.643170